Evaluating the Antiparasitic Activity of Novel BPZ Derivatives Against Toxoplasma gondii

Prevalence studies revealed that one-third of the human population is chronically infected with Toxoplasma gondii. Presently, such infections are without medical treatment that effectively eradicates the parasite once it is in its latent form. Moreover, the therapeutics used to treat acute infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatton, Olivia, Stitzlein, Lea, Dudley, Richard W., Charvat, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466062/
https://www.ncbi.nlm.nih.gov/pubmed/32751616
http://dx.doi.org/10.3390/microorganisms8081159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466062/
https://www.ncbi.nlm.nih.gov/pubmed/32751616
http://dx.doi.org/10.3390/microorganisms8081159

Ejemplares similares